samedan logo

 
 
spacer
home > ebr > spring 2003 > from platform to product - delivering the pipelines of tomorrow
PUBLICATIONS
European Biopharmaceutical Review

From Platform to Product - Delivering the Pipelines of Tomorrow

The demand for new drugs in areas of high unmet medical need or improved drugs for current diseases is immeasurable. Despite its best efforts, the pharmaceutical industry is currently unable to bring enough drugs to the market annually to either sustain or promote its own growth. All eyes are now on the biotech industry where innovative, entrepreneurial spirit and flexibility should provide the ingredients to fuel the pipelines of the future. The successful biotechs will be those companies that have a strong technology platform with a robust drug discovery engine at their core, capable of delivering a stream of diverse and innovative products for treating important disease indications.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Dr Peter Seufer-Wasserthal, Vice President of Business Development at Morphochem AG

Dr Peter Seufer-Wasserthal is Vice President of Business Development at Morphochem AG. Prior to joining Morphochem, he was Director of Business Development Europe of Evotec OAI after having been with Oxford Asymmetry prior to the takeover by Evotec. Before that he was European Sales Manager with Altus Biologics. Dr Seufer-Wasserthal started his industrial career with Chemie Linz (now part of DSM Fine Chemicals) as a Process Chemist before moving into a position as New Business Development Manager.

He received his doctorate degree at the Department of Organic Chemistry, Technical University of Graz, Austria. Dr Seufer-Wasserthal was awarded an Erwin-Schroedinger Fellowship from the Austrian Fond zur Förderung der Wissenschaftlichen Forschung then conducted his post-doctoral studies at the University of Toronto, Canada.

spacer
Dr Peter Seufer-Wasserthal
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Drive for generics sees Korea increasingly attractive to international pharma

Amsterdam, 31st July 2019: Already home to more than 40 pharmaceutical multinationals, Korea is on course to become a global biotech and pharmaceutical hub by 2025, driven by the surge of international partnerships, biosimilars, an expansion in the export of finished formulations and a robust generics market.
More info >>

White Papers

BioT ULT Transporter

BioCision

The growth of biobanking, cell therapy, and complex biopharmaceutical therapies like cancer vaccines has created a strong need for products and processes to ensure the stability of temperature­-sensitive biospecimens. Proper collection, handling, characterization, packaging and shipping of these materials is critical, as poor sample handling impacts researchers working on discovery with patient samples, as well as clinicians treating patients with cutting edge therapies. This white paper describes in detail the BioCision BioT™ ULT Transporter, the first-of-its-kind dry ice-based portable cooling system that maintains a stable -75° to -50°C environment for over 24 hours on one charge of dry ice, enabling reliable handling and transfer of valuable temperature-sensitive biospecimens as part of a larger cold chain standardization process.
More info >>

 
Industry Events

12th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology

23-26 March 2020, Vienna, Austria

In continuation of the very successful scientific meetings in Budapest, Paris, Berlin, Florence, Geneva, Barcelona, Malta, Istanbul, Lisbon, Glasgow and Granada, the 12th PBP World will be held in Vienna from 23 – 26 March 2020. This every two year held conference has gained an ever increasing impact among the pharmaceutical scientists: With up to 1000 submitted abstracts and about 1300 participants it has become a well-established major meeting, attracting scientists from all over the world.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement